Entree Capital
Global early-stage venture capital firm with roots in Israel, investing in technology companies across consumer, enterprise, fintech, and healthcare. Known for backing exceptional founders with global ambitions.
Website
https://entreecap.comLocation
Tel Aviv, Israel / New York, USA
Founded
2010
AUM
$800M+
Investment Range
$500K - $15M
Portfolio Companies
2
Focus
generalist
Fund Stages
seed, series-a, series-b
Investment Thesis
Entree Capital invests in early-stage technology companies globally, with particular expertise in Israeli innovation and US market expansion. In healthcare, they back technology-enabled healthcare companies that can scale across markets, leveraging their global network and operational experience.
Team
Partners / Managing Directors (Health & Bio Focus)
- Aviad Eyal - Co-Founder & Managing Partner
- Adi Peled - Partner
- Eyal Malinger - General Partner
Other Key Team Members
- Investment team across Israel, US, and Europe
Focus Areas
- Healthcare Technology
- Enterprise Software
- Consumer Technology
- Fintech
- Digital Health
- Israeli Innovation
Notable Exits
- Monday.com - IPO (2021, NASDAQ: MNDY)
- Riskified - IPO (2021, NYSE: RSKD)
- Portfolio companies achieving significant growth
Sources
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Omnix Medical | Tel Aviv, Israel | 2017 | medical-devicesantimicrobial+2 |
| Elephant Healthcare | London, UK & Nairobi, Kenya | 2016 | digital-healthhealthcare-technology+3 |